Agenda
Each session will allocate ~ 20 minutes for discussion of opportunities and future directions of the research area(s) and addressing questions from the audience. Meeting recordings will be posted on this page.
January 27, 2023, Friday, 2:00 PM to 3:00 PM, ET
Session I. Keynote Speech
Co-moderators: Diane St. Germain and Weiwei Chen
Keynote Speech: Addressing Comorbidity in Cancer Research: New Considerations for an Older Dilemma, presented by Supriya Mohile, M.D., M.S., University of Rochester Medical Center
February 1, 2023, Wednesday, 1:00 PM to 2:00 PM, ET
Session II. Comorbidities and Cancer Clinical Trial Design
Co-moderators: Jeff Buchsbaum, Diane St. Germain, and Rich Little
Speakers:
Edith P. Mitchell, M.D., Thomas Jefferson University
Andrea Denicoff, R.N., M.S. National Cancer Institute
Harvey Jay Cohen, M.D., Duke University
Unger, Joseph M, Ph.D., M.S., Fred Hutchinson Cancer Research Center
March 30, 2023, Thursday, 3:00 PM to 4:00 PM, ET
Session III. Impact of Comorbidities on Treatment Tolerability and Patient Outcomes
Co-moderators: Rachel Altshuler and Diane St. Germain
Speakers:
Martine Extermann, M.D., Ph.D., H Lee Moffitt Cancer Center & Research Institute
Marie Flannery, Ph.D., University of Rochester Medical Center
Aarti Asnani, M.D., Harvard Medical School
April 12, 2023, Wednesday, 11:00 AM – 12:00 PM, ET
Session IV. Wearable Devices to Measure Comorbidities and Improve Cancer Treatment
Co-moderators: Mike Espey, Piotr Grodzinski, and Carolina Salvador Morales
Speakers:
Wei Gao, Ph.D., California Institute of Technology
Karen M. Mustian, Ph.D., M.P.H., University of Rochester Medical Center
Andrew Laccetti, M.D., M.S., Memorial Sloan Kettering Cancer Center
May 9, 2023, Tuesday, 2:00 PM – 3:15 PM, ET
Session V. Microbiome as A Comorbidity in Cancer Therapy
Co-moderators: Phil Daschner, Mike Espey, and Pat Prasanna
Speakers:
Ann Klopp, Ph.D., University of Texas MD Anderson Cancer Center
Matthew Redinbo, Ph.D., University of North Carolina at Chapel Hill
Peter Turnbaugh, Ph.D., University of California, San Francisco
June 15, 2023, Thursday, 1:00 PM – 2:00 PM, ET
Session VI. Food as a Drug
Co-moderators: Phil Daschner, Mike Espey, and Pat Prasanna
Speakers:
Lydia Lynch, Ph.D., Harvard Medical School
Nicole Simone, M.D., Thomas Jefferson University
July 14, 2023, Friday, 2:00 PM – 3:00 PM, ET
Session VII. Senescence, Cancer Treatment-Associated Accelerated Aging, and Comorbidities
Co-moderators: Jennifer Guida and Weiwei Chen
Speakers:
James L. Kirkland, M.D., Ph.D., Mayo Clinic
Judi Campisi, Ph.D., Buck Institute for Research on Aging